A new study conducted by NeOnc into the efficacy of its NEO 100 formulation to safely deliver therapeutics to the brain through the Blood-Brain Barrier was concluded in August 2020. This study was done to specifically study not only the ability to permeate the BBB but also the impact such migration would have on the […]